Melinta Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2000-01-01
- Employees
- 290
- Market Cap
- -
- Website
- http://melinta.com
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT06672978
A Study Comparing the Bioavailability of a Taste-masked Delafloxacin Powder for Oral Suspension With the Delafloxacin Tablet in Healthy Adults
- First Posted Date
- 2024-09-25
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT06612255
- Locations
- 🇬🇧
Quotient Sciences, Ruddington, Nottingham, United Kingdom
Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-03-14
- Last Posted Date
- 2021-04-13
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 102
- Registration Number
- NCT03873987
- Locations
- 🇺🇸
ML-ORI-102 Study Site, Somers Point, New Jersey, United States
Evaluate Safety and Pharmacokinetic To Assess Bronchopulmonary Disposition of Intravenous Delafloxacin in Healthy Adults
- First Posted Date
- 2018-05-23
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03534622
- Locations
- 🇺🇸
Pulmonary Associates, Phoenix, Arizona, United States
A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Orbactiv® (Oritavancin) for Infections Caused by Gram Positive Bacteria in a Real World Setting
- First Posted Date
- 2017-05-18
- Last Posted Date
- 2018-03-12
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 325
- Registration Number
- NCT03159403
- Locations
- 🇺🇸
Birmingham Infectious Disease and Infusion, Birmingham, Alabama, United States
🇺🇸St. Vincent Hospital and Health Care Center, Inc., Indianapolis, Indiana, United States
🇺🇸Santa Barbara Cottage Hospital, Santa Barbara, California, United States
A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
- First Posted Date
- 2016-12-30
- Last Posted Date
- 2019-01-11
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Registration Number
- NCT03006679
Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-02-10
- Last Posted Date
- 2020-02-27
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 860
- Registration Number
- NCT02679573
- Locations
- 🇺🇦
Melinta 306 Study Site, Zhytomyr, Ukraine
Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2015-11-16
- Last Posted Date
- 2019-01-03
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 97
- Registration Number
- NCT02605122
Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis
- First Posted Date
- 2015-07-29
- Last Posted Date
- 2017-03-21
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT02510599
- Locations
- 🇺🇸
Case Western University Hospitals, Cleveland, Ohio, United States
Study to Evaluate the Effect of Delafloxacin on the Pharmacokinetics of Midazolam in Healthy Subjects
- First Posted Date
- 2015-07-22
- Last Posted Date
- 2016-12-16
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT02505997
- Locations
- 🇺🇸
PPD Development, LP, Austin, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath